Supernus Pharmaceuticals
SUPN
#4437
Rank
A$2.69 B
Marketcap
$48.23
Share price
0.16%
Change (1 day)
7.32%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2024 (TTM): A$0.14 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are A$0.66 Billion. , an increase over its 2023 earnings that were of A$8.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 A$0.15 B1787.92%
2023 A$8.12 M-92.36%
2022 A$0.10 B-29.8%
2021 A$0.15 B-49.79%
2020 A$0.30 B12.99%
2019 A$0.26 B7.58%
2018 A$0.24 B54.9%
2017 A$0.16 B84.25%
2016 A$86.95 M202.27%
2015 A$28.76 M-462.04%
2014 -A$7.95 Million-94%
2013 -A$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.34 Billion-316.65%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.48 B 1,516.33%๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.88 B 12,856.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$13.14 Billion-8,661.36%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.99 B 7,065.63%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.34 B 17,721.60%๐Ÿ‡บ๐Ÿ‡ธ USA